Molecularly, BCR-ABL rearrangements have clearly been demonstrated in megakaryocytic cell lines as well as in megakaryocytes from the vast majority of CML patients [1,3,4,7]. The gene discussed is ABL1; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.